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Abstract
Corneal transplantation is the only option to cure corneal opacities. However, there is an 
imbalance between supply and demand of corneal tissues in the world. To solve the problem of 
corneal shortage, corneal xenotransplantation studies have been implemented in the past years 
using porcine corneas. The corneal xenografts could come from 1) wild type pigs, 2) genetically-
engineered pigs, 3) decellularized porcine corneas, and 4) decellularized porcine corneas that are 
recellularized with human corneal cells, eventually with patients’ own cells, as in all type of 
xenografts. All approaches except, the former would reduce or mitigate recipient immune 
responses. Although several techniques in decellularization have been reported, there is still no 
standardized protocol for the complete decellularization of corneal tissue. Herein, we reviewed 
different decellularization methods for porcine corneas based on the mechanism of action, 
decellularization efficacy, biocompatibility, and the undesirable effects on corneal ultrastructure. 
We compared 9 decellularization methods including: (i) sodium dodecyl sulfate, (ii) triton x-100, 
(iii) hypertonic saline, (iv) human serum with electrophoresis, (v) high hydrostatic pressure, (vi) 
freeze-thaw, (vii) nitrogen gas, (viii) phospholipase A2, and (ix) glycerol with chemical 
crosslinking methods. It appears that combined methods could be more useful to perform efficient 
corneal decellularization.
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1. INTRODUCTION
According to data from the Global Vision Database, 36 million people worldwide are blind.1 
The World Health Organization indicates that corneal opacities account for 5% of all causes 
of blindness.2 When corneal transparency becomes defective, corneal transplantation is the 
only curative option.3 Currently, deceased human donors are the only source of corneal 
grafts. Despite the existence of countries that export corneas, e.g., the United States (that 
accounts for 85% of the world’s corneal ‘exports’), Sri Lanka (9%), and Italy (3%), there is 
a major imbalance between supply and demand.4,5 In the last decade, tissue engineering has 
become a more prominent method of potentially solving the problem of corneal shortage.
Tissue-engineered corneal scaffolds should have complex features that are essential to 
corneal function. These features, which include (i) light transparency, (ii) resistance to 
ultraviolet light, (iii) insensitivity to photons, and (iv) specific tensile strength, make the 
replication of a corneal scaffold from biomaterials much more difficult.6,7 To combat this 
issue, decellularized corneas have been successfully tested in pre-clinical animal studies.
4,8–10 The most significant advantage of a decellularization process is conservation of the 
extracellular matrix (ECM) proteins and mechanical properties of the cornea.8,11 For these 
reasons, a decellularized corneal scaffold could be a good option for creating tissue-
engineered corneal xenografts.
Normally, the cornea is an immune-privileged site, but in some pathological conditions, 
especially infections and after transplantation, this privilege can be diminished.12,13 In 
addition, decellularized porcine corneal xenografts (DPCXs) offer another important 
advantage in that they exhibit a decreased risk of an inflammatory reaction compared to the 
fresh porcine corneal xenografts.14,15 Therefore, DPCXs may provide a basis for successful 
corneal transplantation.8
Decellularization of a three-dimensional matrix scaffold (i.e. organ or tissue, cornea) enables 
the removal of cellular and immunogenic components from an organ/tissue while preserving 
ECM with its native micro- and macroscopic anatomy.16 Many different protocols for 
decellularizing human and porcine corneal tissues have been reported using biological, 
physical and chemical compounds.17–20 However, there is still no standardized protocol. An 
ideal decellularization method should maximize the elimination of cellular components and 
nuclear materials, while limiting the possible detrimental effect on histo-architecture and 
mechanical properties of the ECM. In addition, being able to repopulate host cells (e.g., 
keratocytes, epithelial cells) should be an important factor after decellularization.
In the present review, we will assess favorable, promising, and new decellularization 
protocols and agents for developing DPCXs.
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To date, there has been no documented method that can achieve complete decellularization 
while maintaining the principal properties of the cornea (Table 1). Moreover, the term 
“complete decellularization” is currently not well-defined. Crapo et al.21 suggested that it is 
impossible to remove 100% of cellular material by decellularization techniques and defined 
the term of “sufficient decellularization” by conditioning minimal criteria those are 
following (i) ECM should contain <50ng dsDNA per mg dry weight, (ii) DNA fragments 
should be shorter than 200 bp, and (iii) there should be no visible nuclear component within 
the ECM. Besides decellularization, reduced antigenicity in the collagen tissues of cornea is 
also essential if a recipient immune response is to be prevented. Additional conditions must 
be implemented to reduce edema, maintain or achieve transparency, and increase mechanical 
strength. Albeit, there are numerous procedures and agents to reverse undesirable effects. 
However, the balance between decellularization and damage must be established well in 
advance in order to achieve effective decellularization.
2.1. Sodium Dodecyl Sulfate (SDS)
SDS is a strong ionic detergent and is the most widely used agent in corneal 
decellularization practices (either alone or in combination with other agents) due to its 
extreme efficiency in removing cells and solubilizing cellular membranes.22–30 Numerous 
studies have reported ‘complete’ or ‘sufficient’ decellularization at different concentrations 
and exposure times.19,22–24 However, Sasaki et al. was not able to replicate the findings 
despite using higher concentrations and the same or prolonged time-points.30 These results 
indicate that other conditions, besides exposure time and concentration, may be important to 
reach sufficient corneal decellularization. In this regard, studies have suggested different 
optimal conditions. For instance, Zhou et al. recommended 0.1% (wt/vol) SDS for 7 hours at 
37°C24, Gonzalez-Andrades et al. recommended 0.1% (vol/vol) SDS for 48 hours at room 
temperature with 300 rpm continuous shaking17, and Du and Wu recommended 0.5% (wt/
vol) SDS for 24 hours at 4°C with protease inhibition and continuous shaking22.
Despite its effectiveness in decellularization, SDS has undesirable effects on the cornea 
(especially in high concentrations) including matrix edema, disruption of collagen layers, 
disordered fibrils, and reduced transparency. Nonetheless, these effects can be managed by 
decreasing the concentration and/or exposure time. There is a delicate balance between 
decellularization and damage. Therefore, determining the best conditions with the least 
possible damage to the cornea is of upmost importance.24 To restore transparency (the effect 
of edema, and/or disrupted collagen conformation), glycerol and dextran can be utilized.
20,31,32 In some animal studies, reduced transparency, edema, and disrupted histo-
architecture gradually returned to normality after corneal transplantation.22–24,26
2.2. Triton X-100 (TX)
TX is a non-ionic detergent and the second most commonly-used detergent in corneal 
decellularization experiments.17–19 Its decellularization activity is based on the disruption of 
lipid-to-lipid and lipid-to-protein interactions, but not protein-to-protein interactions.33 The 
efficacy of decellularization agents greatly fluctuates with the tissue being treated. For 
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instance, while TX is able to decellularize cartilage, corneal decellularization studies have 
shown great variability.34 Du et al. found that decellularization of pig corneas using TX was 
unachievable, regardless of high concentrations (5% w/v) and prolonged time (96h).17 
Others have also failed to obtain satisfactory decellularization on pig and human corneas.
17,30,32
These studies suggest that TX alone is not a strong enough detergent to sufficiently 
decellularize corneas. On the other hand, since TX is not able to break protein-to-protein 
interactions, disruption of the histo-architecture is not as complete as with SDS, and there 
remains reduced transparency and edema after use of TX.30,35
2.3. Hypertonic Saline (HS)
HS has been used to decellularize human, porcine, rabbit, and ostrich corneas.3,8,35,36 HS is 
an effective decellularization agent due to its ability to disrupt DNA-to-protein interactions 
and to induce osmotic lysis.21 HS is able to ‘completely’ decellularize corneal tissue on its 
own or in combination with TX, though its effects on natural ultrastructure are variable.
20,29,37 For instance, Lee et al. obtained decellularized opaque corneas by using 1.5 mol/L 
HS for 24 hours, but Luo et al. obtained decellularized transparent corneas by using 2 mol/L 
for 30 min.20,38 HS protocol treated porcine corneas resulted in well-maintained collagen 
fibrils after the transplantation into the rabbit corneal bed.37
Choi et al. transplanted HS-treated and fresh porcine corneas to nonhuman primates. The 
decellularized corneas showed encouraging results over the fresh corneas with less rejection 
rate and longer graft survival.14 On the other hand, TX-assisted HS is one of the methods 
that has been used in a clinical trial.39 A different approach to decellularize corneas was 
implemented in which corneas were first soaked in ultrapure water to induce swelling, after 
which 2 mol/L HS was used to decellularize, followed by a wash with 0.2% TX. 
Dehydration and sterilization has been achieved by using glycerol and cobalt-60 irradiation, 
respectively.39
2.4. Human Serum with Electrophoresis
Galactose-α−1,3-galactose (α-Gal) is the major carbohydrate antigen to porcine cells.40 
Cohen et al. found that α-Gal expression exists in the limbal and stromal areas of porcine 
corneal tissue but not in the endothelium and epithelium.41 However, Lee et al. demonstrated 
increased α-Gal expression in all layers of cornea after xenotransplantation.42 The protocol 
(originally reported by Shao et al.43) is based on the cytotoxic effect of human serum to α-
Gal antigenic wild-type porcine cells through binding of anti-Gal IgM and IgG antibodies, 
which induce complement-mediated cell destruction.43 This method equates with the effect 
of pig corneas in which α-Gal gene-knockout has been achieved by genetic engineering. 
Anterior and posterior lamellas have been used separately after decellularization, and the 
results showed a decreasing number of cells in the anterior, but not posterior, stroma.43 
These findings indicate heterogeneity of corneal stromal structure and keratocytes.
The aim of using electrophoresis after exposure to human serum is to enhance the removal 
of dead cells. Evaluation of the biomechanical properties and collagen fibril interactions of 
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DPCX demonstrated ultrastructural similarity to native corneas, with remarkable 
transparency.44
2.5. High Hydrostatic Pressure (HHP)
The main decellularization mechanism of the HHP method is the disruption of cellular 
membranes. In this method, a pressure of 980 MPa or 10.000 kPa is applied to the cornea for 
10 min at 10°C or 30°C. In order to achieve sufficient decellularization and maintain corneal 
histoarchitecture, corneas must then be washed with PBS or EGM-2 medium containing 
dextran and DNase I.10,18,30 Applying the HHP method at 10°C instead of 30°C maintained 
collagen fibrils and interactions to a greater extent.45 When compared to TX and SDS, HHP 
preserved more glycosaminoglycans, removed more DNA content, and decellularization was 
achieved in a shorter time-frame.45,46 Hashimoto et al. have performed anterior lamellar and 
intra-lamellar keratoplasties in animals, and showed that corneal transparency was preserved 
without any immune reaction for 6 months.10,18 HHP has many advantages, especially 
maintaining the native histo-architecture of the cornea, but the high expense of this 
technology is seen as a disadvantage.
2.6. Freeze-Thaw
Freezing and thawing lyses and removes the cells to produce a decellularized graft. Freezing 
can be carried out at −80°C (freezer) or −196°C (liquid nitrogen), and thawing should be 
carried out at a biological temperature of 37°C.47 Li et al. achieved sufficient 
decellularization through a freeze-thaw method by using different adjuvants, including 
DNase, RNase, and Tris hydrochloride, resulting in corneas that were transparent.48 
Subsequent transplantation in rabbits showed consistent transparency, with no immune 
reaction for 3 months. However, neovascularization and inflammation was observed in 
amniotic membrane transplanted group during the same period.48 Lin et al. applied the 
freeze-thaw method in a different way, and were unable to obtain transparent corneas.49 
However, after transplantation into rabbits, the corneas gradually regained transparency and 
the angiogenesis that developed immediately after transplantation started to regress after the 
first two weeks.49 Van den Bogerd et al. have successfully used the freeze-thaw method on 
anterior capsule of the lens to make a useful scaffold for corneal endothelial cells (CECs).50
2.7. Nitrogen (N2) Gas
The decellularization mechanism of N2 gas is by inducing apoptosis through the creation of 
a hypoxic environment. Amano et al. reported decellularization with complete transparency 
after treatment of porcine corneas with N2 gas for 7 days at room temperature. Furthermore, 
after transplantation in rabbits, N2 gas-treated corneas maintained transparency for 6 
months.51 The maintenance of transparency could be a major advantage of the N2 gas 
method. However, future studies need to demonstrate the effects of decellularization on the 
mechanical strength and ultrastructure of N2 gas-treated corneal stroma. Lee et al. compared 
modified and classic N2 gas methods on porcine corneas, including methods using 2800 
centi-gray irradiation and 4% TX. The modified methods were associated with ‘complete’ 
decellularization only when N2 gas treatment was combined with TX treatment.20
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2.8. Phospholipase A2 (PLA)
PLA is a specific type of esterase which breaks down the ester bonds between the second 
fatty acid and the glycerol molecule of membrane glycerophospholipids. PLA activation 
requires a significant Ca2+ concentration.52 Wu et al. accomplished the sufficient 
decellularization of porcine corneas using PLA and sodium deoxycholate. Staining with 
hematoxylin and eosin demonstrated no cells or cellular components, but a small amount of 
nucleonic acid debris was detected on transmission electron microscopy. No significant 
change in mechanical properties and ultrastructure was observed. Lamellar keratoplasty 
performed in rabbits showed maintained transparency and significant biocompatibility, such 
that no immunological reaction occurred in the 12 months after transplantation.9
2.9. Glycerol with Chemical Crosslinking
Chemical crosslinking is defined as the intermolecular or intramolecular joining of two or 
more molecules by a covalent bond.53 The general purpose of using crosslinkers is to 
modify the mechanical, biological, and degradation properties of hydrogels.54 Lin et al. used 
glycerol to decellularize porcine corneas by creating a high osmotic pressure.55 Thereafter, 
decellularized corneas were treated with a crosslinker (1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide/N-hydroxysulfosuccinimide) to improve biomechanical and biocompatibility 
properties, while also maintaining transparency. Additionally, this group used γ-irradiation 
to reduce immunogenicity. Following completion of these procedures, transparent and 
mechanically-stable corneas were obtained. Lamellar keratoplasty was performed in rabbits 
to treat fungal keratitis, and demonstrated that corneal grafts effectively controlled the 
infection while also maintaining transparency.55
2.10. Other Decellularization Methods
Sodium deoxycholate is an ionic detergent that can sufficiently decellularize corneal tissue, 
but only if treated for an extended period of time. This protocol has negative effects which 
result in the disruption of corneal histo-architecture, including Descement’s membrane and 
Bowman’s layer.19
‘Complete’ decellularization was not achieved by 3-((3-cholamidopropyl) 
dimethylammonio)-1-propanesulfonate (CHAPS, a zwitterionic detergent). In certain 
conditions, it resulted in the destruction of the corneal histo-architecture.18 Benzalkonium 
chloride is a cationic surfactant that was unable to ‘completely’ decellularize corneal tissue. 
Undesired effects occurred, including collagen damage and alteration of the fibrillary 
pattern.17 Octylphenoxypolyethoxyethanol (Igepal) is a non-ionic detergent that has been 
previously used for heart valve, pericardial, and vein decellularization.17 Although Igepal 
preserved the proteoglycans and fibrils very well, it was unable to achieve a significant 
percentage of decellularization.17
Trypsin is a protease that hydrolyses peptide bonds, and ethylenediaminetetraacetic acid 
(EDTA) is a chelating agent; the trypsin-EDTA combination has only been used in human 
corneal tissue engineering once, and was demonstrated to be a more effective way to 
decellularize corneas than SDS and TX. Furthermore, the trypsin-EDTA method preserved 
natural corneal features to a greater extent than did SDS and TX.23
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Ideally, decellularized porcine corneas should have suitable stroma and surface features that 
allow for repopulation by multiple human corneal cell lines, including endothelial cells, 
keratocytes, and epithelial cells. However, creating an endothelial sheet (ES) might be the 
most important challenge to overcome. Unlike murine, rabbit, and bovine cells, human 
CECs have limited proliferative capability in vivo.56 Although decellularized and layered 
human corneal lamellae have shown biocompatibility with human CECs, making 
endothelialized human lamellae a feasible option for endothelial keratoplasty in the future. 
Currently, re-endothelialization by human CECs is only possible in vitro.57,58 This is a 
limitation of decellularized corneas that cannot be directly used in many corneal diseases 
with endothelial cell damage.
A comparative study found that the acellular human lens capsule is a better scaffold to create 
ES when compared with human Descemet’s membranes and human amniotic membranes.50 
Lee et al. demonstrated a porcine model of corneal endothelialization, and successfully 
obtained an ES on DPCXs with porcine CECs.20 Recellularization of the posterior portion of 
the DPCXs with human CECs is necessary in order to perform endothelium included 
keratoplasties. Yoeruek et al. completed an DPCX endothelialization with hCECs by using a 
modified SDS method with EDTA and aprotinin for decellularization. However, in vitro 
studies are needed to investigate the biocompatibility of other decellularization methods.23
In animal studies, freeze-thaw, N2 gas, HHP, and SDS-treated DPCXs displayed 
repopulation of recipient keratocytes in graft stroma after lamellar keratoplasty.10,22,48,51 
However, the recellularization activity of PLA and glycerol combined with chemical 
crosslinking seems to be a preferred alternative.9,57 On the other hand, SDS- and HS-treated 
DPCXs successfully repopulated with human keratocytes in vitro.23 HS has been found to 
be a convenient protocol for recellularization through its establishment of a more ideal 
environment for human keratocytes.23,28 Decellularized human corneas, by using PLA, have 
also been shown to have sufficient biocompatibility with human keratocytes.59 Human 
adipose-derived stem cells have also been used to recellularize decellularized human 
corneas, and differentiate into functional keratocytes in the stroma.60 This same technique 
exhibited functional biocompatibility with thin human corneal stromal laminas (created by 
femtosecond laser) which were successfully and safely transplanted into patients in a clinical 
trial.61 As an alternative to injections and cell cultures, bioreactor platforms can be a useful 
technique for the recellularization of stroma.
Epithelial repopulation of the cornea is a simpler process than repopulation of the other 
layers. Adequate graft epithelization has been detected on DPCXs obtained through different 
decellularization methods, including PLA, HHP, and freeze-thaw.9,10,48,49 In animal studies, 
Hashimoto et al. demonstrated the complete epithelialization of DPCXs within 3 months 
after lamellar keratoplasty.10 Likewise, the seeding of human limbal corneal epithelial cells 
onto the anterior surface of DPCXs resulted in successful epithelialization in 5–8 days.23
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In order to reach ‘sufficient or complete’ decellularization with less damage to the cornea, 
combinations of a strong and a weak decellularization agent might be useful. For instance, in 
2015, Zhang et al. reported the results of the first known clinical trial by using DPCXs. 
Hypertonic saline was used to prepare the DPCXs with Triton-X 100. Lamellar keratoplasty 
was performed on 47 patients who had fungal keratitis, and progress was documented over 
three years.39 This study showed the safety and efficiency of using DPCXs to treat fungal 
keratitis, and encouraged more applications with new indications.39 In a recent clinical trial, 
Shi et al. reached the sufficient decellularization mainly using high hydrostatic pressure but 
they also utilized distilled water, glycerol, endonucleases and a protective medium. Lamellar 
keratoplasty was performed on 23 patients who had different type of corneal ulcers. This 
study also showed the safety of DPCXs for corneal ulcers with 22/23 graft survival for one 
year.62 Therefore, we suggest that combined methodologies should be used for ‘sufficient’ 
corneal decellularization.
Besides immune rejection and infection recurrence, xenozoonosis is also one of the most 
important concerns post-operatively. In the all potential microorganisms, porcine 
endogenous retrovirus (PERV) is the most significant vector for cornea.63,64 To date, no 
evidence has yet shown that PERV can be transmitted to hosts in preclinical and clinical 
trials.39,62
In conclusion, currently DPCXs seem to be the most viable option to use in corneal 
transplantation with limited indications (Figure 1). However, a Korean group is currently 
planning to initiate a clinical trial of corneal xenotransplantation using fresh porcine 
corneas65, thus bringing corneal xenotransplantation as a clinical therapy one step closer.
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What can decellularized porcine corneal xenografts (DPCXs) offer to corneal 
xenotransplantation?
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Table 1:
Advantages and disadvantages of decellularization methods and bioprinting for replacing the cornea






Harms ECM, lamellar structure.
Causes collagen fibril disorganization.
Reduces transparency.
17, 22, 23, 24, 26








17, 30, 32, 35
Hypertonic Saline Maintains ECM.
Removes cellular
components sufficiently.
Used in a clinical trial.
Mixed reports on transparency.
Causes edema.














Used in a clinical trial.
Expensive.










N2 Gas Maintains transparency. Causes edema.
Studies needed on mechanical
strength.
20, 51




Additional treatment needed to achieve
sufficient decellularization.
9
Glycerol with Chemical Crosslinking Maintains corneal
transparency and
mechanical properties.
Small amount of residual nucleic acids. 54
Legend: ECM = Extracellular matrix
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